ORIC Pharmaceuticals Inc (ORIC)
9.315
+0.48
(+5.49%)
USD |
NASDAQ |
May 01, 16:00
9.315
0.00 (0.00%)
After-Hours: 17:56
ORIC Pharmaceuticals Shareholders Equity (Quarterly): 224.09M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 224.09M |
| September 30, 2023 | 247.41M |
| June 30, 2023 | 268.80M |
| March 31, 2023 | 202.81M |
| December 31, 2022 | 222.35M |
| September 30, 2022 | 214.82M |
| June 30, 2022 | 236.87M |
| March 31, 2022 | 253.08M |
| December 31, 2021 | 272.98M |
| Date | Value |
|---|---|
| September 30, 2021 | 291.54M |
| June 30, 2021 | 258.32M |
| March 31, 2021 | 276.08M |
| December 31, 2020 | 289.78M |
| September 30, 2020 | 184.38M |
| June 30, 2020 | 195.25M |
| March 31, 2020 | -98.42M |
| December 31, 2019 | -90.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-98.42M
Minimum
Mar 2020
291.54M
Maximum
Sep 2021
202.94M
Average
236.87M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp | 247.95M |
| Verastem Inc | 57.37M |
| Karyopharm Therapeutics Inc | -136.21M |
| Syndax Pharmaceuticals Inc | 554.20M |
| Arvinas Inc | 660.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.01M |
| Total Liabilities (Quarterly) | 27.92M |